JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 13, 2008, 10.2967/jnmt.107.049627
doi:10.2967/jnmt.107.049627
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnmt.107.049627v1
36/4/200    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laffon, E.
Right arrow Articles by Ducassou, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laffon, E.
Right arrow Articles by Ducassou, D.
Journal of Nuclear Medicine Technology Volume 36, Number 4, 2008 200-202
© 2008 by Society of Nuclear Medicine

The Effect of Renal Failure on 18F-FDG Uptake: A Theoretic Assessment

Eric Laffon1–3, Anne-Laure Cazeau1, Antoine Monet1, Henri de Clermont1, Philippe Fernandez1, Roger Marthan2,3 and Dominique Ducassou1

1 CHU de Bordeaux, Service de Médecine Nucléaire, F-33600 Pessac, France; 2 Université Bordeaux 2, Laboratoire de Physiologie Cellulaire Respiratoire, F-33076 Bordeaux, France; and 3 INSERM U885, F-33076 Bordeaux, France

Correspondence: For correspondence contact: Eric Laffon, Service de Médecine Nucléaire, Hôpital du Haut-Lévèque, avenue de Magellan, 33604 Pessac, France. E-mail: elaffon{at}u-bordeaux2.fr

This work addresses the issue of using 18F-FDG PET in patients with renal failure. Methods: A model analysis has been developed to compare tissue 18F-FDG uptake in a patient who has normal renal function with uptake in a theoretic limiting case that assumes tracer plasma decay is tracer physical decay and is trapped irreversibly. Results: This comparison has allowed us to propose, in the limiting case, that the usually injected activity be lowered by a factor of 3. We also proposed that the PET static acquisition be obtained at about 160 min after tracer injection. These 2 proposals were aimed at obtaining a similar patient radiation dose and similar tissue 18F-FDG uptake. Conclusion: In patients with arbitrary renal failure (i.e., between the 2 extremes of normal function and the theoretic limiting case), we propose that the injected activity be lowered (without exceeding a factor of 3) and that the acquisition be started between 45 and 160 min after tracer injection, depending on the severity of renal failure. Furthermore, the model also shows that the more severe the renal failure is, the more overestimated is the standardized uptake value, unless the renal failure indirectly impairs tissue sensitivity to insulin and hence glucose metabolism.

Key Words: 18F-FDG PET radiation dose; renal failure; 18F-FDG kinetic modeling




This article has been cited by other articles:


Home page
J. Nucl. Med. Technol.Home page
E. Laffon, O. Barret, R. Marthan, and D. Ducassou
Is the Physical Decay Correction of the 18F-FDG Input Function in Dynamic PET Imaging Justified?
J. Nucl. Med. Technol., June 1, 2009; 37(2): 111 - 113.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2008 by the Society of Nuclear Medicine Technologist Section.